EUVIMEDEUVIMED entdecken
Crossref

Design and synthesis of 2-amino-4-(trifluoromethyl)pyrimidine derivatives as potential Werner-dependent antiproliferative agents

Chang You, Shijiao Wei, Jia Yu, Guangcan Xu, Huimin Li, Xinyu Liu, Menghan Wang, Xueling Meng, Youyin Xu, Gang Yu, Heng Luo, Bixue Xu

Molecular Diversity · 2026

DOI: 10.1007/s11030-025-11225-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2026. Verfasst von Chang You und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China. Hauptthemen laut MEDLINE: Pyrimidines, Antineoplastic Agents, Drug Design, Werner Syndrome Helicase. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Natural Science Foundation of Guizhou Province, the Guizhou Province "Hundred" Level Innovative Talent Training Project, National Natural Science Foundations of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To uncover novel inhibitors of Werner (WRN) helicase, this study adopted the scaffold-hopping strategy to design and synthesize 24 novel 2-amino-4-(trifluoromethyl)pyrimidine derivatives. The MTT assay was employed to evaluate the anticancer activity of target compounds against microsatellite instability-high (MSI-H) cell lines (HCT116 and LNCaP) and microsatellite stability (MSS) cell lines (SW620 and PC3). Some compounds demonstrated significant inhibitory activity against all four cancer cell lines. Specifically, compounds 11c, 11f, 11 g, 11 h, and 11 l exhibited greater inhibitory effect toward MSI-H cells (HCT116 and LNCaP) compared to MSS cells (SW620 and PC3). The most active compound 11 g exhibited excellent cellular selectivity, with IC50 values of 1.52 and 1.72 μM against MSI-H cell lines (HCT116 and LNCaP), respectively, while the IC50 values of 11 g against MSS cell lines (SW620 and PC3) were 4.24 and 2.78 μM, respectively, followed by the compound 11 h, whose IC50 values against HCT116, LNCaP, SW620, and PC3 cell lines were 2.22, 1.6, 2.37, and 3.21 µM, respectively. The results of apoptosis induction and cell cycle arrest experiments indicate that compounds 11 g and 11 h induced early apoptosis in HCT116 cells, and G2/M phase cell cycle arrest. This finding was further validated through molecular docking analysis and cellular thermal migration and enzyme activity experiments. The results of WRN helicase inhibition assays showed that the IC50 value of compound 11 g was 6.61 µM. In summary, our study identifies 2-amino-4-(trifluoromethyl)pyrimidine derivative 11 g as potential WRN-dependent anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesAntineoplastic AgentsDrug DesignWerner Syndrome HelicaseHumansCell ProliferationCell Line, TumorMolecular Docking SimulationStructure-Activity RelationshipApoptosisDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

2-aminopyrimidine-4-(trifluoromethyl)AntiproliferativeWerner helicase

Substanzen

PyrimidinesAntineoplastic AgentsWerner Syndrome HelicaseWRN protein, human

Autor:innen und Institutionen

  • College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China.
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang, 550014, China.
  • Natural Products Research Center of Guizhou Province, Guiyang, 550014, China.
  • School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, China.
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang, 550014, China. luo_heng@gmc.edu.cn.
  • Natural Products Research Center of Guizhou Province, Guiyang, 550014, China. luo_heng@gmc.edu.cn.

Förderung

  • Natural Science Foundation of Guizhou Province
  • the Guizhou Province "Hundred" Level Innovative Talent Training Project
  • National Natural Science Foundations of China
  • the Guizhou Province “Hundred” Level Innovative Talent Training Project

Zitieren

APA

You, C., Wei, S., Yu, J., Xu, G., Li, H., Liu, X., Wang, M., Meng, X., Xu, Y., Yu, G., Luo, H., & Xu, B. (2026). Design and synthesis of 2-amino-4-(trifluoromethyl)pyrimidine derivatives as potential Werner-dependent antiproliferative agents. Molecular Diversity. https://doi.org/10.1007/s11030-025-11225-3

Vancouver

You C, Wei S, Yu J, Xu G, Li H, Liu X, et al. Design and synthesis of 2-amino-4-(trifluoromethyl)pyrimidine derivatives as potential Werner-dependent antiproliferative agents. Molecular Diversity. 2026. doi:10.1007/s11030-025-11225-3

BibTeX
@article{You2026,
  author = {You, Chang and Wei, Shijiao and Yu, Jia and Xu, Guangcan and Li, Huimin and Liu, Xinyu and Wang, Menghan and Meng, Xueling and Xu, Youyin and Yu, Gang and Luo, Heng and Xu, Bixue},
  title = {Design and synthesis of 2-amino-4-(trifluoromethyl)pyrimidine derivatives as potential Werner-dependent antiproliferative agents},
  journal = {Molecular Diversity},
  year = {2026},
  doi = {10.1007/s11030-025-11225-3}
}
Kostenlos starten →